Converse Gray High Tops
HeartWare International Announces Appointment Of Katrin Leadley
contained on this page is provided by an independent third party content provider. WorldNow and this Station make no warranties or representations in connection therewith.
is a member of the Russell 2000 and its securities are publicly traded on The NASDAQ Stock Market.
Information Converse Sale Uk 2018
"HeartWare would like to recognize and express our gratitude toward Dr. David Hathaway who has provided excellent stewardship during the past six years," said Godshall. HeartWare values Dave numerous, meaningful contributions and wishes him well in his retirement, as our organization continues to grow and build upon the foundation he helped us create."
This announcement contains forward looking statements that are based on management Converse Baby Shoes
In addition, Leadley has held managerial positions at several other life sciences companies based in California, including Advanced Stent Technologies in Pleasanton, Pulmonx in Palo Alto, and Quintiles/The Lewin Group in San Francisco.
"Katrin has a wealth of clinical program management experience, and we are confident she will be a great addition to our team," said Doug Godshall, President and Chief Executive Officer. "Her knowledge of cardiovascular device trials and her relationships with many of our international key opinion leaders will enable her to begin making contributions immediately. Katrin has proven experience in identifying new market opportunities, ensuring patient safety and executing clinical development plans and regulatory strategies to achieve product approvals and market introductions of new medical therapies. Katrin will help lead HeartWare through our next stage of clinical and commercial growth, as we advance our ongoing trials, initiate new studies and move toward obtaining regulatory approval of devices in our pipeline."
beliefs, assumptions and expectations and on information currently available to management. Converse Shoes White Women
HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare Ventricular Assist System features the HVAD pump, a small full support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 40 countries. clinical trial for destination therapy.
Leadley earned her medical degree at Ludwig Maximilian University Medical School in Munich. She also was awarded a National Institute of Health Postdoctoral Fellowship by the School of Public Health at the University of California at Berkeley.
HEARTWARE, HVAD, MVAD, PAL, SYNERGY, CIRCULITE and HeartWare logos are registered trademarks of HeartWare, Inc.
During her time at JenaValve, Leadley oversaw the company global clinical programs and worldwide regulatory strategy. She provided leadership and guidance as the company safety officer for all JenaValve products throughout the product lifecycle, and she offered medical guidance to the organization Research Development, marketing and physician training programs. She was also responsible for the company scientific communications and for collaborating with key opinion leaders in the field.
FRAMINGHAM, Mass., Aug. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including Quintiles, Boston Scientific Corporation and JenaValve Technology in Munich, where she spent the last three years as CMO leading the company clinical, regulatory, scientific and medical activities.
Previously, Leadley spent eight years at Boston Scientific based in San Jose, California and Munich where she most recently served as Global Senior Medical Director, Clinical Sciences. During her time at Boston Scientific, Leadley oversaw the implementation of worldwide policies and processes for the medical and clinical sciences function of the cardiovascular platforms. and Europe.
All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward looking statements, including without limitation our expectations with respect to the commercialization of the HeartWare Ventricular Assist System, continued support from international customers, progress of clinical trials and post approval studies, regulatory status, research and development activities and our ability to take advantage of acquired and pipeline technology. Management believes that these forward looking statements are reasonable as and when made. However, you should not place undue reliance on forward looking statements because they speak only as of the date when made. HeartWare does not assume any obligation to publicly update or revise any forward looking statements, whether as Converse Gray High Tops a result of new information, future events or otherwise, except as may be required by federal securities laws and the rules and regulations of the Securities and Exchange Commission. HeartWare may not actually achieve the plans, projections or expectations disclosed in forward looking statements, and actual results, developments or events could differ materially from those disclosed in the forward looking statements. Forward looking statements are subject to a number of risks and uncertainties, including without limitation those described in Part I, Item 1A. "Risk Factors" in HeartWare Annual Report on Form 10 K filed with the Securities and Exchange Commission. HeartWare may update risk factors from time to time in Part II, Item 1A "Risk Factors" in Quarterly Reports on Form 10 Q, Current Reports on Form 8 K, or other filings with the Securities and Exchange Commission.
Converse Gray High Tops
Converse BlueHome / Converse Gray High Tops
Converse Green And Black
Converse White Leather Sneaker
Gucci Belt Pic
Converse Zip Shoes
Ferragamo Belt Matte Black
Converse Shoes Colors
White Converse Mens High Tops
Converse Shoes High Cut
Converse Dark Blue
Lv Belts White
Converse Mint Green High Tops
Converse Chuck 2 Knit
Ferragamo Belt Double Gancini
Hermes Belts Black